Abstract:
Objective This study aimed to evaluate the value of liquid-based cytology test(LCT)combined with high-risk human papillomavirus(HR-HPV)testing in cervical intraepithelial neoplasia grade Ⅲ(CIN Ⅲ)after large-loop excision of the transformation zone(LLETZ)during follow-up.
Methods Clinical analysis was used to investigate 567 patients diagnosed with CIN Ⅲ and treated with LLETZ from May 2003 to May 2009 at Peking University Shenzhen Hospital.The patients were enrolled in a follow-up program set at 3 months, 6 months, and every 6 to 12 months.LCT and HR-HPV testing were used as monitoring indicators to evaluate HR-HPV testing after LLETZ during follow-up.
Results 1) The residual lesion predicting capacity of postoperative LCT obtained the following: sensitivity, 60%: specificity, 88.15%: positive predictive value, 8.30%;and negative predictive value, 99.19%.The residual lesion predicting capacity of HPV testing obtained the following: sensitivity, 100%: specificity, 85.64%: positive predictive value, 11.11%;and negative predictive value, 100%.The recurrent lesion predicting capacity of postoperative LCT obtained the following: sensitivity, 63.64%;specificity, 92.27%;positive predictive value, 14.00%;and negative predictive value, 99.23%.The recurrent lesion predicting capacity of HPV testing obtained the following: sensitivity, 72.73%;specificity 85.97%;positive predictive value 9.30%;and negative predictive value, 99.38%.2)The recurrent lesion rate was higher in postoperative persistent HPV infection patients than in non-postoperative persistent HPV infection patients, Ther were statistically significant differences between the persistent negative and non-testing preoperative group(P < 0.05).The recurrence rate was higher in persistent HPV-positive and HPV-re-infected patients than in the negative conversion group, whereas no recurrent lesion was found in persistent HPV-negative patients.
Conclusion Resultsshowed the importance of predicting residual and recurrent lesions by LCT and HR-HPV testing, which were also confirmed to be effective methods in follow up.Postoperative persistent HPV-positive status is associated with recurrence and requires consistent follow-up.